semaglutide and heart attack 2026 Update: is now an approved medication for cardiovascular diseases. It is recommended for the treatment of Type 2 diabetes secondary prevention of cardiovascular complications in adults with established semaglutide cardiovascular outcomes news 2025

CrossRef Disparities in trends of metabolic syndrome in Korea from 2007 to 2022 by age, sex, and lifestyle factors Yaelim Kim, Yeonghun Choi, Kyu-Na Lee, Hyunji Sang, Kyungdo Han, Sunyoung Kim, Sang Youl Rhee Scientific Reports.2025;[Epub] CrossRef The Effectiveness of Telemedicine for Glycemic (Hba1c) Management of Patients with Diabetes Mellitus Type 2: A Meta-Analysis Santy Irene Putri, Nisa'i Daramita Supriyono, Asruria Sani Fajriah, Prima Soultoni Akbar Majalah Kesehatan Indonesia.2025;[Epub] CrossRef Using digital tools to improve diabetes care in India with continuous glucose monitoring Jothydev Kesavadev, Banshi Saboo, Manoj S

Trulicity was Lillys first GLP-1 medication, launched in 2015

The Science Behind GLP-1s and Hot Flashes Emerging research highlights a potential link between GLP-1 receptor agonists and the reduction of hot flashes